A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor support.
Haematologica
; 103(6): 1054-1064, 2018 06.
Article
in En
| MEDLINE
| ID: mdl-29472361
Full text:
1
Database:
MEDLINE
Main subject:
Hydroxyprostaglandin Dehydrogenases
/
Granulocyte Colony-Stimulating Factor
/
Enzyme Inhibitors
/
Graft Survival
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Adult
/
Animals
/
Female
/
Humans
/
Male
Language:
En
Journal:
Haematologica
Year:
2018
Type:
Article
Affiliation country:
United States